RSS Feed for Latest Medical Headlines on RxPG News

Medical Research Health Special Topics World

 
  Home
 
   Health
 Aging
 Asian Health
 Events
 Fitness
 Food & Nutrition
 Happiness
 Men's Health
 Mental Health
 Occupational Health
 Parenting
 Public Health
 Sleep Hygiene
 Women's Health
 
   Healthcare
 Africa
 Australia
 Canada Healthcare
 China Healthcare
 India Healthcare
 New Zealand
 South Africa
 UK
 USA
 World Healthcare
 
   Latest Research
 Aging
 Alternative Medicine
 Anaethesia
 Biochemistry
 Biotechnology
 Cancer
 Cardiology
 Clinical Trials
 Cytology
 Dental
 Dermatology
 Embryology
 Endocrinology
 ENT
 Environment
 Epidemiology
 Gastroenterology
 Genetics
 Gynaecology
 Haematology
 Immunology
  Autoimmune Diseases
  Immunosupressants
  Monoclonal Antibodies
   Infliximab
 Infectious Diseases
 Medicine
 Metabolism
 Microbiology
 Musculoskeletal
 Nephrology
 Neurosciences
 Obstetrics
 Ophthalmology
 Orthopedics
 Paediatrics
 Pathology
 Pharmacology
 Physiology
 Psychiatry
 Radiology
 Rheumatology
 Sports Medicine
 Surgery
 Toxicology
 Urology
 
   Medical News
 Awards & Prizes
 Epidemics
 Launch
 Opinion
 Professionals
 
   Special Topics
 Ethics
 Euthanasia
 Evolution
 Feature
 Odd Medical News
 Climate
Search

Latest Research : Immunology : Monoclonal Antibodies
  Last Updated: Nov 1, 2009 - 11:48:48 PM

Latest Research : Immunology : Monoclonal Antibodies : Infliximab
FDA grants priority review of infliximab for children with Crohn's disease
Centocor, Inc. announced today that the supplemental Biologics License Application (sBLA) for REMICADE (R) (infliximab) for the treatment of pediatric Crohn's disease has been accepted and designated for Priority Review by the U.S. Food and Drug Administration (FDA). Centocor is seeking approval for the treatment of moderately to severely active pediatric Crohn's disease in patients who have had an inadequate response to conventional therapies. Currently, there are no approved biologic therapies for the treatment of pediatric Crohn's disease, a chronic, potentially debilitating condition that causes inflammation of the gastrointestinal tract, typically resulting in symptoms such as diarrhea, fever, abdominal pain and weight loss. Children with Crohn's disease may also experience delayed development and stunted growth. Orphan drug designation was granted by the FDA to REMICADE for the treatment of pediatric Crohn's disease on November 12, 2003. In addition, on August 30, 2004 a REMICADE Phase 3 clinical development program for pediatric Crohn's disease was designated Fast Track by the FDA.
Apr 5, 2006 - 2:05:37 PM

Latest Research : Immunology : Monoclonal Antibodies : Infliximab
CHMP approves Infliximab for the treatment of moderate to severe plaque psoriasis
Centocor BV and Schering-Plough Corporation announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) issued a positive opinion recommending the approval of an expanded indication for REMICADE (infliximab).
Aug 1, 2005 - 11:19:38 PM

<< prev next >>

 
Headlines
Health  
Defensin-1 in honey can work as antibiotic
A key mechanism links virgin olive oil to protection against breast cancer
South Asians more prone to heart attacks than whites
More than skin deep, tanning product of sun's rays
FDA should adopt risk-based approach to food safety
Obesity remains an economic issue, Seattle obesity study finds
Food insecurity leads to adverse health consequences in pregnancy
IOM report recommends framework to evaluate science behind health claims for foods and drugs
Social context may be a better indicator of obesity disparities than race
Creating new healthy ingredients by innovative milling techniques and processes for cereal grains
Healthcare  
Four more encephalitis deaths in Uttar Pradesh
Medical college in Kalpana Chawla's name coming up in Karnal
Vitamin A Supplementation Programme to Stay
Frame policy for kidney transplants, court asks government
NRHM completes five years, rural health still in disarray
Azad overrules IMA's objections to rural MBBS course
Biotech industry hails tax sops in Indian budget
Junior doctors in Madhya Pradesh call off strike
25000 NRI Doctors Could Return to India from UK
AIIMS to guide 40 medical colleges on drug reaction
Latest Research  
Medical Cannabis beneficial for chronic pain control
T-tubule disruption occurs before decline in heart function detectable
Microfluidic tool for isolating neutrophils
Asking women about reproductive coercion reduced the likelihood that the women would continue to experience such pressures
ORNL graphite foam technology licensed to LED North America
Southampton to conduct UK's first cochlear implant operation to give sound in both ears
National Geographic features University of Miami's work on Bahamas 'blue holes'
Experimental treatments for cocaine addiction may prevent relapse
Core values unite Americans, despite divisions
Vitamin A increases the presence of the HIV virus in breast milk
Medical News  
6 dead, 1,200 sick as diarrhoea hits Doda in Jammu region
Dengue spurs sales in mosquito repellents, launch of new products
'Delhi dengue situation as bad as 2006'
Two CRPF recruits collapse in training session, die
Chandigarh man dies of swine flu
Government denies HPV vaccine role in reported deaths
India, China account for 45 percent multi-drug resistant TB
Government taking steps to retain best doctors: Azad
95 swine flu deaths in Karnataka till Aug 25
By 2030, India's diabetes population will reach 79 mn
Special Topics  
'Primodial Soup' theory for origin of life rejected in paper
Human species could have killed Neanderthal man
History, geography also seem to shape our genome
3,000 Kerala medical students to attend inter-college meet
Tamil Nadu seeks to control deemed universities
Spiders which eat together, stay together and multiply
Anna Hazare - the keeper of the earth and human conscience
Indian American scientist wins top IMO prize
Artificial human sperm could make men redundant: experts
Will autopsy on Benazir's body become necessary?

All rights reserved by RxPG
Contact Us